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1 Introduction
There is a wide variety of data in HIV/AIDS research. In clinical studies,
common variables include CD4 cell count, HIV-1 RNA (viral load), demographics,
WHO or CDC disease stage, and time-to-event variables such as time from ART
initiation to an AIDS defining event, viral failure, or death. Biomarker data are common
in both clinical and basic studies of HIV; these may include markers of inflammation,
pharmacokinetics, drug use, or metabolism, and may be biomarkers commonly used in
other disease settings (e.g., diabetes or hepatitis). Genomic data, both human and viral,
are also important.
Of course, the characteristics of these and other variables used in HIV research
are extremely diverse. The distribution of some are fairly symmetric (e.g., age at ART
initiation), somewhat skewed (e.g., CD4 count), or highly skewed (e.g., viral load).
Many variables are left censored at detection limits (e.g., viral load and other
biomarkers) or right censored due to finite follow-up (e.g., time to death). Many are
ordered categorical (e.g., stage of disease and single nucleotide polymorphisms). Much
of the statistical work in the analysis of HIV data involves finding proper models for
these variables to assess associations, to predict outcomes, and hopefully in the end to
improve patient and public health. Given the diversity of variables, a wide variety of
statistical models are used.
There are benefits to having statistical methods that are robust and efficient
across a wide variety of data types. Such methods can be quickly applied with
confidence in many different situations and may be useful as a first pass in big data
settings (e.g., datasets with many variables of interest). Such methods may also be
useful in smaller analyses because they provide nice, simple summaries. Spearman’s
rank correlation is one such example: its simplicity, validity, and utility across a wide
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variety of orderable variables makes it popular in practice.
We have developed a new type of residual, the probability-scale residual (PSR),
which is remarkably useful and well defined across a wide variety of variable types and
models (Li and Shepherd, 2010, 2012; Shepherd et al., 2016). As a residual it can be
used for model diagnostics and for inference. We have proposed to use the correlation of
PSRs to adjust Spearman’s rank correlation for covariates (Liu et al., 2017). The goal of
this chapter is to introduce the PSR to HIV researchers, to describe a few of its
important properties, and to demonstrate its utility across a diverse set of analyses with
HIV data. We first introduce the PSR and describe some of its properties (section 2).
We then illustrate its use for model diagnostics (section 3) and inference (section 4).
Several datasets that we have encountered in our collaborative HIV/AIDS research will
be used to illustrate the methods. The final section discusses a few points and proposes
directions for future research. Analysis code for all of the data examples is available at
our website, biostat.mc.vanderbilt.edu/ArchivedAnalyses.
2 Probability-scale Residual
In linear regression, a residual is defined as y − yˆ, where y is an observed value
and yˆ is a fitted value, typically the estimated expectation of the outcome conditional on
covariates. This observed-minus-expected residual (OMER) is simple and has many
desirable properties, but is not easily extendable to outcomes where conditional
expectations are difficult to calculate or are not meaningful. For example, for ordinal
outcomes there is no natural definition of difference or conditional expectation unless
scores are assigned to the ordered categories; for right censored outcomes with partially
defined fitted distributions one may not be able to calculate the conditional expectation.
Furthermore, the OMER may be misleading with models where one is fitting a
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non-symmetric distribution to data.
The OMER can be thought of as the expectation of the difference between the
observed value, y, and a random variable, Y ∗, from the fitted distribution with cdf F ∗:
E(y − Y ∗) = y − yˆ. Instead of using the difference to contrast y and Y ∗, one could use
the sign function, specifically, sign(y, Y ∗), where sign(a, b) is −1, 0, and 1 for
a < b, a = b, and a > b, respectively. The PSR is simply the expectation of this contrast,
r(y, F ∗) = E {sign(y, Y ∗)}, which can be written in terms of probabilities as
P (Y ∗ < y)− P (Y ∗ > y) or equivalently F ∗(y−) + F ∗(y)− 1.
A few benefits of the PSR are immediately apparent. First, the sign function is
more generally applicable than the difference, so by contrasting variables with the sign
function we are able to define a residual for more types of outcomes. Second, the PSR
does not require estimation of conditional expectation but rather estimation of the
conditional distribution itself. Note that it is not necessary to estimate the entire
distribution, but the distribution only needs to be estimated at the observed value, y.
Hence, the residual is flexible for a wide range of outcome variables (including ordered
categorical) and models (including semiparametric), while still providing information on
model fit.
We originally introduced the PSR for use with ordered categorical variables
(Li and Shepherd, 2010, 2012). In that setting, the residual has several nice properties
including the following:
1. The PSR captures order information without assigning arbitrary numbers to the
ordinal categories.
2. The PSR yields only one value per observation regardless of the number of
categories of the ordinal variable.
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3. The PSR has expectation zero with a correctly specified model; i.e., for a random
variable Y with distribution F , E{r(Y, F ∗)} = 0 if F ∗ = F .
In addition to the above, the PSR is the only residual that satisfies several natural
properties for ordinal outcomes such as the branching property (Brockett and Levine,
1977), reversability, and monotonicity with respect to the observed value. Details are in
Li and Shepherd (2012). For proportional odds models, the PSR sums to 0.
The PSR is also well defined for other types of orderable data, including binary,
count, continuous, and censored outcomes (Shepherd et al., 2016). In all cases, the PSR
has expectation zero under correctly specified models. With continuous data, the PSR
equals zero at the median of the fitted distribution. In addition, with continuous data
the random variable r(Y, F ∗) is uniformly distributed between −1 and 1 if the fitted
distribution is correctly specified, suggesting that with sufficiently large sample sizes,
one can approximately assess model fit by comparing the distribution of PSRs with a
uniform(−1, 1) distribution. With binary data, the PSR is simply the OMER, or the
unscaled Pearson residual. With right censored data, the PSR is a function of the
observed minimum of the censoring and event times, y, and the indicator that an event
occurred, δ: r(y, F ∗, δ) = F ∗(y)− δ {1− F ∗(y−)}. Given δ, the PSR with time-to-event
data is a one-to-one function of the martingale, deviance, and Cox-Snell residuals. The
PSR can also be written for current status data. Details are in Shepherd et al. (2016),
where we also demonstrated the calculation and the utility of the PSR in a variety of
settings including normal linear models, least squared regression, exponential regression
models, median/quantile regression, semi-parametric transformation models, Poisson
and negative binomial regression, Cox regression, and the analysis of current status data.
Although novel, the PSR is related to other methods proposed in the statistical
literature. The PSR was part of a test statistic in genetic analysis of ordinal traits
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(Zhang et al., 2006). The PSR is closely related to ridits (Bross, 1958) and can be
thought of as a linear transformation of an observed value’s adjusted rank (see Section
4). With continuous data, the PSR is simply a re-scaling of the probability integral
transformation, which has been previously proposed for assessing goodness of fit
(Pearson, 1938; David and Johnson, 1948) and as a component of a residual
(Cox and Snell, 1968; Davison and Tsai, 1992; Dunn and Smyth, 1996). One of the
strengths of the PSR is its unification of several of these concepts into a single residual.
3 Model Diagnostics
As a residual, the PSR can be useful for model diagnostics. In this section, we
introduce a few HIV datasets and demonstrate the residual’s use in these settings.
3.1 Stage of Cervical Lesions: Proportional Odds Models
Cervical specimens from 145 HIV-infected women in Zambia were examined
using cytology and categorized into five ordered stages; 10 specimens were normal, 26
atypical squamous cells of undetermined significance (ASCUS), 35 low grade
intraepithelial lesions, 49 high grade intraepithelial lesions, and 30 suspicious for cancer
(Parham et al., 2006). Other data were collected from the women including age, CD4
count, education, and frequency of condom use (never, rarely, almost always, always).
There is interest in modeling the association between these variables and stage of
cervical lesions. To this end, we fit proportional odds models with stage of cervical
lesions as the outcome and various combinations of the other variables as predictors.
The left panel of Figure 1 shows a residual-by-predictor plot with the x-axis showing age
and the y-axis showing PSRs from a proportional odds model with age and CD4
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included as linear predictors; a lowess curve demonstrating the smoothed relationship
between the residuals and age is also included. When age is included in the proportional
odds model as a linear variable, there appears to be a quadratic relationship between
the PSRs and age: the model tends to over-predict severity of lesions at low and high
ages. For example, a 23-year old woman in the dataset with a CD4 count of 309
cells/mm3 had predicted probabilities of 0.10, 0.25, 0.27, 0.27, and 0.11 for cytology
being normal, ASCUS, low, high, and cancerous, respectively. This suggests that her
observed cytology of ASCUS was less severe than predicted by the model – resulting in
a residual of 0.10− (0.27 + 0.27 + 0.11) = −0.55 (left-most residual in the left panel). If
both linear and quadratic terms of age are included in the proportional odds model, the
quadratic relationship between the residuals and age is no longer seen (right panel),
suggesting a better model fit. The observed ASCUS cytology for the 23-year old woman
is now more consistent to what the model predicts (probability of normal, ASCUS, low,
high, and cancerous estimated as 0.26, 0.38, 0.21, 0.12, and 0.03, respectively), resulting
in a PSR closer to zero: 0.26− (0.21 + 0.12 + 0.03) = −0.11.
3.2 Biomarker Study of Metabolomics: Semiparametric
Transformation Models
HIV-positive individuals who have been on long term antiretroviral therapy
(ART) appear to be at an increased risk of cardiometabolic diseases, including diabetes,
compared to HIV-negative individuals. Plasma levels of amino acids and other small
molecules reflective of impaired energy metabolism, such as acylcarnitines and organic
acids, were measured with mass spectrometry to provide a detailed metabolic profile for
70 non-diabetic, HIV-infected persons who were on efavirenz, tenofovir, and
emtricitabine with an undetectable viral load for over 2 years (Koethe et al., 2016).
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Figure 1: Probability-scale residual-by-predictor plots with age included in a proportional
odds model as a linear term (left panel) and with a linear and quadratic term (right panel).
These plots are reproduced with permission from Biometrika (Li and Shepherd, 2012).
There is interest in assessing associations between these biomarkers and
demographic/clinical variables. In this section, we will focus on modeling a specific
biomarker, 2-hydroxybutyric acid, which is thought to be an early indicator of insulin
resistance in non-diabetic persons; elevated serum 2-hydroxybutyric acid has been seen
to predict worsening glucose tolerance. 2-hydroxybutyric acid is fairly skewed, ranging
from 13 to 151 µM, median 34 µM in our dataset. Even after a log-transformation, the
distribution remains slightly right-skewed with some outlier levels. Predictor variables
for our model include age, sex, race, body mass index (BMI), CD4 cell count, smoking
status, and ART duration (log transformed).
Because of the skewness of the biomarker outcome, we favor fitting a
semiparametric transformation model, specifically Y = T (βZ + ǫ), where T (·) is an
unspecified monotonic increasing transformation and ǫ is a random error with a specified
parametric distribution Fǫ (Zeng and Lin, 2007). The conditional distribution of Y
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given Z is therefore
FY |Z(y) = P (T (βZ + ǫ) ≤ y)
= P (ǫ ≤ T−1(y)− βZ)
= Fǫ(T
−1(y)− βZ).
Hence, the semiparametric transformation model can be written in a manner similar to
that of the ordinal cumulative probability model, g[FY |Z(y)] = α(y)− βZ, with the link
function g(·) = F−1ǫ (·) and the intercept α(y) = T
−1(y). Harrell (2015) has proposed
using this fact to estimate parameters from the semiparametric transformation model
with continuous data by maximizing an approximated multinomial likelihood, and he
has implemented this procedure, denoted as orm, in R statistical software as part of his
popular ‘rms’ package.
In our biomarker analysis, we fit three models of 2-hydroxybutyric acid (denoted
as Y ) on covariates: (1) a multivariable linear regression model with Y untransformed;
(2) a multivariable linear model with Y log-transformed; and (3) a semiparametric
transformation model fitted using orm with the link function g(·)=log(−log(·)), which
corresponds to assuming Fǫ follows an extreme value distribution. Figure 2 shows
quantile-quantile (QQ) plots of PSRs from each of these models compared to quantiles
from a Uniform(−1, 1) distribution. If the model is correctly specified, the residuals
should be approximately uniformly distributed. Clearly PSRs from the normal linear
model are far from uniform, and although PSRs from the linear model after
log-transforming the biomarker are closer to being uniform, PSRs from the flexible,
semiparametric transformation model are more uniform.
In this analysis, we could also have used OMERs to uncover lack of fit for the
linear models. However, the OMER is difficult to calculate for the semiparametric
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Figure 2: QQ plots of PSRs from linear (left), linear after log-transformation (center),
and semiparametric transformation models (right) of 2-hydroxybutyric acid compared to
a Uniform(−1,1) distribution.
transformation model because it requires computation of the conditional expectation,
and even if we went through the process of estimating the conditional expectation for all
observed covariate combinations, OMERs would still be skewed and not very good for
model diagnostics because the semiparametric transformation model makes no
assumptions of symmetry of the OMERs, equal variance, etc. In contrast, the PSR is
easily and naturally calculated from the fitted semiparametric transformation model and
makes no additional assumptions beyond that of the original model. Hence, the PSR is
useful for comparing fit across the three different models because it is on the same scale
for each; with the PSR, one is comparing apples with apples, so to speak.
Figure 3 shows residual-by-predictor plots for continuous covariates from the
semiparametric transformation model using PSRs. There is some evidence of non-linear
relationships (top panel). The model was re-fit expanding age, BMI, and
log-transformed ART duration using restricted cubic splines with 3 knots.
Residual-by-predictor plots from these models are given in the bottom panel of Figure 3.
There is no longer evidence of non-linear residual relationships. A likelihood ratio test
confirms that the second model with the non-linear terms is a better fit (p=0.010);
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Figure 3: Residual by predictor plots. The smoothed relationship is shown using lowess
curves. The top panels show PSRs versus continuous predictors from an initial model
fit without splines. The bottom panels show PSRs versus continuous predictors after
expanding age, BMI, and log-transformed ART duration using restricted cubic splines
with 3 knots.
despite the added model complexity, the AIC for the model with the non-linear terms is
lower than that without them (599 vs. 605).
4 Inference
Because the PSR is applicable to and has a common scale across a wide variety
of outcome types, it can be used to test for conditional associations using residual
correlation. We describe these tests for residual correlation using PSRs in Section 4.1
and show their connection with Spearman’s rank correlation in Section 4.2.
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4.1 Tests of Residual Correlation
We initially developed the PSR as a component of an approach for testing the
association between two ordinal variables, X and Y while controlling for covariates Z
(Li and Shepherd, 2010). Our approach was to fit separate multinomial models (e.g.,
proportional odds models) of X on Z and Y on Z, obtain residuals from these models,
and then test the association between residuals from these models. This is analogous to
linear regression where the association between Y and X conditional on Z is captured
by the correlation between OMERS from linear models of X on Z and of Y on Z. We
could not find a good residual for ordinal outcomes that resulted in a single value per
observation and captured the necessary residual information without imposing
assumptions additional to those imposed by the original model – hence, we created the
PSR. In Li and Shepherd (2010), we proposed three test statistics for testing the
conditional association between X and Y , one of which was simply the sample
correlation between PSRs from the two models. We showed that our test statistics equal
zero under the null hypothesis of independence between Y and X conditional on Z, and
we derived their large sample distributions. Collectively, we referred to our test statistics
as COBOT (conditional ordinal by ordinal tests).
We found that these test statistics performed well in simulations, finding a nice
balance between power and robustness. For example, if data were simulated from a
proportional odds model with a linear relationship between the log-odds of Y and the
labels of the ordinal predictor X conditional on Z, then our COBOT methods resulted
in minimal loss of power compared to the gold standard analysis of simply fitting a
proportional odds model with X included as a continuous variable. Under this scenario,
the power of COBOT was much higher than models treating ordinal X as a categorical
variable that ignored the order information. And when data were generated such that
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the log-odds of Y and the labels of the ordinal predictor X was non-linear conditional
on Z, then the power of COBOT was higher than that of approaches that included X in
the proportional odds model as a continuous variable or a categorical variable. Details
are in Li and Shepherd (2010).
It would be disingenuous to claim that COBOT always outperforms other
approaches. For example, COBOT has poor power to reject the null of conditional
independence when the relationship between X and Y conditional on Z is not
monotonic. Also, subsequent simulations have suggested that the advantages of COBOT
depend on the number of categories of the ordinal variable and the probability
distribution of those categories. For example, if an ordinal variable, X , has few
categories (i.e., 2-3) then there appears to be little advantage to using COBOT over
simply treating X as a categorical predictor variable in a proportional odds model,
whereas when there are lots of categories (i.e., > 7), treating the ordinal variables as
continuous seems to perform reasonably well, even with non-linear relationships. These
caveats noted, we believe that COBOT fills an important gap in the statistical literature
regarding methods to test the conditional association between two ordinal variables
while accounting for their ordinal nature.
Because of its applicability and common scale with a wide variety of outcomes,
the correlation of PSRs can also be used to test for conditional associations in more
general settings. For example, using the correlation of PSRs, one could test for
association between continuous, count, or ordinal X and continuous, count, or ordinal Y
conditional on Z.
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4.2 Spearman’s Partial and Conditional Rank Correlations
Consider a model of an ordinal outcome Y with a constant predictor for all
subjects (i.e., a model with only an intercept). With such a model, the predicted
probability for each category is simply its empirical distribution (nj/n), and the PSR is
therefore a linear transformation of the ranks of Y . As such, when there are no
covariates, the correlation coefficient between PSRs from models for X and Y is
equivalent to Spearman’s rank correlation. When covariates are present, the PSR can be
thought of as a linear transformation of the adjusted ranks of subjects and our test
statistic can be thought of as an adjusted rank correlation. This also holds for
continuous outcomes and other types of ordered discrete variables (e.g., count data),
and suggests an approach for extending Spearman’s rank correlation to account for
covariates.
More formally, the population parameter of Spearman’s rank correlation, denoted
as γXY , is the scaled difference between the probability of concordance and the
probability of discordance between (X, Y ) and (X0, Y0), where X0 and Y0 have the same
marginal distributions as X and Y , denoted F and G, respectively, but X0 ⊥ Y0 and
(X0, Y0) ⊥ (X, Y ) (Kruskal, 1958). With continuous X and Y the scaling factor is 3,
which ensures that −1 ≤ γXY ≤ 1; for non-continuous X and/or Y , the scaling factor is
a function of the marginal distributions of the non-continuous variables (Neslehova,
2007). It can be shown that this difference between concordance and discordance
probabilities is equal to the covariance of PSRs (from unconditional models), and the
scaling factor is simply the inverse of the square root of the product of the variances of
the PSRs (Liu et al., 2017). Specifically,
γXY = c{P [(X −X0)(Y − Y0) > 0]− P [(X −X0)(Y − Y0) < 0]}
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= cCov[r(X,F ), r(Y,G)]
= corr[r(X,F ), r(Y,G)].
Note, as highlighted in Section 2, that with continuous variables and correct model
specification, the PSR is uniformly distributed from −1 to 1 and hence has variance 1/3,
leading to a scaling factor of c = 3; with discrete random variables, the variance of the
PSR is Var[r(X,F )] = (1−
∑
f 3x)/3,where fx = P (X = x), which leads to the scaling
factor for Spearman’s correlation with discrete variables. Therefore, Spearman’s rank
correlation can be written as the correlation of PSRs. Similarly, Spearman’s rank
correlation conditional on Z can be defined as
γXY |Z = cZ{P [(X −X0)(Y − Y0) > 0|Z]− P [(X −X0)(Y − Y0) < 0|Z]}
= corr[r(X,FX|Z), r(Y,GY |Z)|Z],
the conditional correlation between PSRs from models conditional on Z. This expression
is equivalent to Spearman’s conditional rank correlation for continuous variables recently
proposed by Gijbels et al. (2011). Unlike Gijbels et al. (2011), however, our conditional
rank correlation using PSRs can also be easily applied to discrete variables. Such a
statistic describes how the rank correlation between X and Y varies as a function of Z.
Finally, we define Spearman’s partial rank correlation as
γXY ·Z = c
∗{P [(X −X0)(Y − Y0) > 0|Z]− P [(X −X0)(Y − Y0) < 0|Z]}
= corr[r(X,FX|Z), r(Y,GY |Z)],
which is a weighted average of γXY |Z . Partial correlations describe the association
between X and Y after adjusting for Z, but not as a function of Z. Details are in
15
Liu et al. (2017).
These observations fill another gap in the literature. Pearson’s partial correlation
is derived as the correlation between OMERs from models of Y on Z and X on Z.
When Z is a single variable, this is equivalently written as
(ρXY − ρXZρY Z)/
√
(1− ρ2XZ)(1− ρ
2
Y Z), where ρXY denotes Pearson’s correlation
between X and Y and so forth. The traditional Spearman’s partial correlation has been
proposed by substituting ρAB with the corresponding rank correlations, γAB. Although
not a poor measure of association, this traditional Spearman’s partial correlation is ad
hoc and does not correspond with a sensible population parameter (Kendall, 1942;
Gripenberg, 1992). In contrast, Spearman’s partial rank correlation defined as the
correlation of PSRs directly corresponds to the population parameter of Spearman’s
rank correlation and is elegantly analogous to the definition of Pearson’s partial
correlation – instead of the correlation of OMERs it is the correlation of PSRs.
The above arguments are made at the population level. In practice, one must fit
models of Y on Z and X on Z to compute the partial Spearman’s rank correlation.
Given the flexibility of the PSR to a wide variety of models, the choice of models for Y
on Z and X on Z are almost unlimited. However, the choice of model is still important
to ensure adequate fit for investigating residual correlation. For example, if a model of
Y on Z poorly fits the data, then residual correlations from this model may be
misleading. To be true to the robust nature of Spearman’s rank correlation, yet to be
efficient, we favor fitting semiparametric models that only use the order information of
the outcomes for models of Y on Z and X on Z. Specifically, we favor using the
semiparametric transformation model described in Section 3.2 with Y = T (βZ + ǫ),
where T (·) is an unspecified monotonic increasing transformation and ǫ is a random
error with a specified parametric distribution Fǫ (Zeng and Lin, 2007). A similar model
is fit for X on Z. An advantage of the semiparametric transformation model is that it
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can be fit to binary, ordered categorical, and continuous variables. In practice, we have
used orm, introduced in Section 3.2, to obtain maximum likelihood estimates based on
the semiparametric transformation model. Extensive simulations have shown that
Spearman’s partial correlation using PSRs performs remarkably well with orm, even
when models are misspecified (e.g., orm with a cloglog, instead of probit, link is fit to
normal data) (Liu et al., 2017).
Computation of conditional Spearman’s rank correlations can also be computed
using PSRs from semiparametric transformation models. If Z is categorical, then this
correlation can simply be calculated in each level of Z. With continuous Z, the
conditional rank correlation can be computed either nonparametrically with, for
example, kernal smoothers, or modeled with parametric functions (Liu et al., 2017).
4.3 Covariance of PSRs
In COBOT, we proposed 3 test statistics. One of them, the correlation between
PSRs, has been described above as an extension of Spearman’s rank correlation to
account for covariates. A second COBOT test statistic was to compare the observed
values of (X, Y ) with the distribution of possible values under the null that X and Y are
independent conditional on Z using the difference of concordance-discordance
probabilities. It can be shown that this is equivalent to the expectation of the product
of PSRs, E[r(Y, FY |Z), r(X,GX|Z)], which with correctly specified models is simply the
covariance of PSRs. Hence, not surprisingly, we could also use the covariance of PSRs as
a test statistic. Although some interpretation is lost when using the covariance, it may
have advantages over the correlation when modeling the rank association between X
and Y as a function of Z because it only requires modeling E[r(X,FX|Z)r(Y,GY |Z)|Z].
In contrast, models of Spearman’s conditional rank correlation with discrete data also
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require modeling Var[r(X,FX|Z)] and Var[r(Y,GY |Z)|Z].
4.4 Examples
4.4.1 Stage of Cervical Lesions
Returning to the Zambia dataset of Section 3.1, there is interest in assessing the
association between stage of cervical lesions and condom use, after controlling for other
variables. Stage of cervical lesions and condom use are both ordered categorical
variables. The unadjusted Spearman’s rank correlation is −0.057 (p-value=0.50). Using
the methods described above, Spearman’s partial rank correlation was estimated to be
−0.037 (95% CI −0.196, 0.123; p-value=0.65), adjusted for age, age2, CD4, education,
and marital status.
4.4.2 Biomarker Study of Metabolomics
Returning to the biomarker study of Section 3.2, there is interest in assessing the
correlation between plasma levels of various metabolites to better understand how these
molecules interact among persons infected with HIV who have been on long term
antiretroviral therapy. There were 21 primary biomarkers measured on 70 HIV-infected
patients. Data were complete except for a single patient who was missing a measurement
of OGIS 120. The distributions of the biomarkers are quite heterogenous (data not
shown), many are right skewed (e.g., 2-hydroxybutyric acid highlighted in Section 3.2),
some have several patients with values below assay detection limits, and pairwise
associations are not expected to be linear. The biomarkers’ scales vary and there is little
interest in obtaining interpretable regression coefficients. For these reasons, Spearman’s
rank correlations between biomarkers would be ideal because of their robustness and
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their single number summary of the strength of association on a common scale between
−1 and 1. However, other variables could be associated with various biomarkers that we
would like to control for, including age, sex, race, BMI, CD4 cell count, smoking status,
and ART duration. Hence, we also computed Spearman’s partial rank correlation using
the correlation of PSRs from models that adjusted for those variables. This was done by
fitting a model for each biomarker using a semiparametric transformation model with
the covariates listed above (with ART duration log-transformed) and estimating via orm
with a logit link. (Results were very similar when using a complementary log-log link,
and are not shown.) As illustrated in Section 3.2, some of these models may have
benefited from including non-linear relationships between covariates and biomarkers
using splines; however, with only 70 patients, over-fitting could be an issue. Also, these
estimates are meant to be a first pass that could lead to further investigation, perhaps
fine-tuning model fit using diagnostics as done in Section 3.2.
Figure 4 shows Spearman’s rank correlation for all pairs of biomarkers; the
quantities to the upper-left of the diagonal are unadjusted, the quantities to the
lower-right of the diagonal are adjusted using the correlation of PSRs. Red and blue
shading indicates positive and negative correlation, respectively, and black boxes are
drawn around those correlations that are significantly different from 0 (i.e., p-values
< 0.05). The figure demonstrates that many of the correlations are reduced after
adjusting for these additional variables. For example, HOMA 2 insulin sensitivity
appears to be correlated (positively or negatively) with many of the other biomarkers,
with 15 of the 20 unadjusted pairwise correlations significantly different from 0.
However, after controlling for covariates the correlations generally weakened with point
estimates closer to 0 and only 5 of 20 adjusted pairwise correlations significantly
different from 0. A similar reduction in correlation is observed for the lactate biomarker.
Although correlations generally weakened after controlling for other variables, this was
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Figure 4: Heatmap showing the pairwise Spearman’s rank correlations between 21
biomarkers. The upper-left correlations are unadjusted, the lower-right correlations are
partial correlations adjusted for age, sex, race, BMI, CD4, smoking status, and ART
duration. Colors denote the correlation with those closer to −1 and 1 being more blue
and red, respectively. Those correlations that are significantly different from 0 at the
α = 0.05-level are boxed.
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not always the case. For example, the rank correlation between hemoglobin A1C and
glutamic acid increased from 0.22 to 0.29 after controlling for covariates, and the rank
correlation between alpha-ketogluterate and pyruvate increased from 0.22 to 0.31 in the
presence of covariates.
4.4.3 Genome-wide Association Study
As an additional illustration of our methods, we use the correlation of PSRs to
examine the potential association between single nucleotide polymorphism (SNPs) and
tenofovir clearance among patients randomized to the tenofovir/emtricitabine arm in
AIDS Clinical Trials Group Protocol A5202. Tenofovir causes kidney toxicity in some
patients and there is interest in identifying SNPs that may be associated with plasma
tenofovir clearance, as these SNPs may in turn be associated with risk of kidney
toxicity. An earlier genome-wide association study (GWAS) looked at the association
between approximately 890,000 SNPs and tenofovir clearance using standard methods
(Wanga et al., 2015). In these analyses, the association between SNPs and tenofovir
clearance was modeled using linear regression adjusting for sex, age, BMI, other
antiretrovirals (efavirenz or ritonavir boosted atazanavir), baseline creatinine clearance,
self-reported race (white, black, Hispanic, or other), and the first two principal
components for genetic ancestry. SNPs were included in those models assuming additive
effects; i.e., for bi-allelic markers with alleles A and a, genotypes A/A, A/a, and a/a
were coded as 0, 1, and 2.
Genotype can be thought of as an ordered categorical variable, and there may be
benefits to treating it as such in a GWAS. In particular, genetic effects may be additive
(as assumed by the analysis model given above), dominant, or recessive, and it would be
desirable to have a single analysis that is robust for detecting monotone associations
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between SNPs and tenofovir clearance without specifically assuming effects are either
additive, dominant, or recessive. To that end, we repeated the GWAS using the
correlation of PSRs. Specifically, we regressed tenofovir clearance on the same covariates
adjusted for in Wanga et al. (2015) with the exception that SNPs were not included in
the model, and we also fit proportional odds models of SNPs based on these same
covariates. PSRs were then derived from all models; for the linear model we used an
empirical estimate of the distribution of the residuals to compute PSRs (i.e.,
PSRi =
∑n
j=1 I(ǫˆj < ǫˆi)/n−
∑n
j=1 I(ǫˆj > ǫˆi)/n, where ǫˆi is the OMER for subject i). We
then computed the correlation between PSRs from the tenofovir clearance model and
PSRs from the SNP models (i.e., Spearman’s partial rank correlation), and computed
p-values under the null hypothesis of no residual correlation. Finally, for purpose of
comparison, we repeated all analyses fitting linear models in a manner identical to that
of Wanga et al. (2015) except using dominant, recessive, and categorical specifications
for the SNPs. Specifically, this amounts to coding (A/A, A/a, a/a) as (0, 1, 1) for
dominant, (0, 0, 1) for recessive, and using two (dummy) variables coded as (0, 1, 0) and
(0, 0, 1) for categorical which therefore ignores the order information.
Table 1: TDF clearance: Correlation matrix of p-values in GWAS.
corr(PSRs) Additive Dominant Recessive Categorical
corr(PSRs) 1
Additive 0.801 1
Dominant 0.709 0.734 1
Recessive 0.204 0.326 0.067 1
Categorical 0.557 0.649 0.643 0.653 1
Table 1 shows a pairwise Spearman’s correlation matrix of the approximately
890,000 p-values using the five different analysis models. P-values between the residual
correlation and additive models were strongly correlated (γ = 0.801); results from the
residual correlation model were also highly correlated with the dominant model
(γ = 0.709), less so with the categorical model (γ = 0.557), and weakly correlated with
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the recessive model (γ = 0.204). Table 2 shows the top 10 SNPs under each analysis
model, and their respective p-values. SNP rs12387850 was ranked first in the correlation
of PSRs analysis (p-value = 2.80× 10−7), additive (p-value = 1.26× 10−6) and dominant
models (p-value = 5.63× 10−7), but ranked the 75th (p-value = 1.07× 10−5) and 26th
(p-value = 3.71× 10−6) in the recessive and categorical models respectively. Among the
SNPs significantly associated with tenofovir clearance, SNP rs12082252 ranked 1st
(p-value = 2.28× 10−10) and 2nd (p-value = 1.69× 10−9) in the recessive and categorical
models respectively, but was ranked much lower in the other model specifications
(346688th using the correlation of PSRs, 1924th in additive, 90918th in dominant).
Table 2: TDF clearance: SNPs with the smallest p-values in combined group analysis
corr(PSRs) Additive Dominant Recessive Categorical
CHR SNP P CHR SNP P CHR SNP P CHR SNP P CHR SNP P
2 rs887829 7.08e-10 2 rs887829 2.24e-11 2 rs3755319 1.03e-07 2 rs887829 4.49e-12 2 rs887829 1.74e-12
2 rs4148325 2.54e-09 2 rs4148325 7.30e-11 19 rs4239638 3.74e-07 2 rs4148325 8.81e-12 2 rs4148325 4.60e-12
2 rs6742078 4.87e-09 2 rs6742078 1.32e-10 19 rs7257832 4.52e-07 2 rs6742078 5.13e-11 2 rs6742078 1.69e-11
2 rs4148324 1.04e-08 2 rs4148324 3.11e-10 2 rs4663333 4.68e-07 2 rs929596 1.02e-10 2 rs929596 2.48e-11
2 rs10179091 1.63e-08 2 rs929596 3.39e-10 2 rs4663967 5.17e-07 2 rs4148324 1.05e-10 2 rs4148324 4.39e-11
2 rs3771341 3.07e-08 2 rs3771341 3.89e-10 2 rs4399719 8.00e-07 2 rs3771341 3.36e-10 2 rs3771341 6.07e-11
2 rs929596 3.63e-08 2 rs10179091 3.15e-09 2 rs4124874 1.03e-06 2 rs17862875 6.46e-09 2 rs17862875 2.92e-09
2 rs3755319 4.34e-08 2 rs17862875 1.56e-08 2 rs4663965 1.48e-06 2 rs10179091 2.48e-08 2 rs10179091 1.01e-08
2 rs4148326 6.53e-08 2 rs2221198 2.04e-08 2 rs6431628 2.17e-06 2 rs4148326 6.00e-08 2 rs4148326 5.80e-08
2 rs2221198 1.34e-07 2 rs4663969 2.24e-08 11 rs1560994 2.50e-06 2 rs2221198 1.86e-07 2 rs2221198 6.47e-08
2 rs4663969 1.93e-07 2 rs3755319 2.38e-08 2 rs17862866 2.77e-06 2 rs4663969 2.68e-07 2 rs3755319 7.48e-08
2 rs4663967 2.43e-07 2 rs4148326 2.73e-08 2 rs3806597 2.96e-06 2 rs16862202 2.69e-07 2 rs7604115 7.53e-08
2 rs4663333 2.81e-07 2 rs7604115 2.94e-08 2 rs2008595 3.90e-06 2 rs7556676 4.01e-07 2 rs4663969 7.94e-08
2 rs7556676 2.84e-07 2 rs7556676 3.05e-08 2 rs4294999 3.91e-06 2 rs7604115 4.46e-07 2 rs7556676 1.15e-07
2 rs871514 4.07e-07 2 rs871514 4.00e-08 10 rs7915217 4.02e-06 19 rs8111761 2.67e-06 2 rs4663967 2.53e-07
2 rs4294999 4.80e-07 2 rs4663967 5.55e-08 2 rs871514 4.12e-06 7 rs1395381 2.80e-06 2 rs4663333 2.58e-07
2 rs4663965 5.48e-07 2 rs4663333 5.97e-08 2 rs4663963 4.63e-06 3 rs9310867 4.57e-06 2 rs871514 2.87e-07
2 rs4399719 5.65e-07 2 rs4294999 6.26e-08 19 rs8108083 4.68e-06 12 rs7303705 4.87e-06 14 rs2353726 3.55e-07
2 rs3806597 6.46e-07 2 rs4663965 1.16e-07 6 rs199634 5.13e-06 4 rs3866838 5.14e-06 2 rs4294999 4.28e-07
2 rs7604115 6.46e-07 2 rs4663963 1.33e-07 19 rs2377572 5.64e-06 9 rs7847905 5.53e-06 2 rs4663965 5.99e-07
These results are fairly consistent with extensive simulations in which we
generated data under different scenarios (additive, dominant, recessive, and non-linear;
and with different minor allele frequencies) and investigated the power of the correlation
of PSRs to detect associations under the various scenarios (Wanga, 2014). The
correlation of PSRs had greater power to detect associations than the recessive and
dominant models (except, of course, when the data were generated under these models).
The correlation of PSRs did well when the true association was additive, resulting in
only a slight loss of power when compared with models that were correctly specified as
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additive. However, the correlation of PSRs struggled to detect associations generated
under the recessive model; categorical models were better at detecting these recessive
associations and even additive models performed as well as the correlation of PSRs in
the recessive case. Hence, although it is certainly reasonable to analyze GWAS data
using the correlation of PSRs, the benefits of this approach are not as apparent in this
setting as in some others. This is somewhat expected: with only three categories, the
loss of power by treating ordinal SNP data as categorical is likely minimal.
5 Discussion
We have described a new residual, the probability-scale residual, and
demonstrated its use for diagnostics and inference in several settings using actual HIV
data. We believe the PSR should be the go-to residual for the analysis of ordered
categorical data and semiparametric transformation models fit to continuous data. The
PSR is also useful in many other settings that are illustrated elsewhere (see
Shepherd et al. (2016)), including time-to-event outcomes. In some of these settings,
existing residuals are available that offer similar information to the PSR. However, as
seen in Section 3.2, there are advantages to having a residual that is defined across
multiple classes of models, as residuals on the same scale become easier to directly
compare fit across model classes. Because it is bounded between −1 and 1, the PSR is
poor at detecting outliers. (It should be noted that in some analyses [e.g.,
semiparametric transformation models and quantile regression] the analysis model down
weights the influence of outliers, so residual plots that are dominated by ‘outliers’ are
actually inconsistent with the model that was fit and may not be desirable.) If outlier
detection is desired, a simple transformation of the PSRs (e.g., Φ−1{(PSR+ 1)/2} with
Φ−1(·) denoting the inverse cdf of the standard normal distribution) allows their
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detection. There are certainly other diagnostics for which residuals more specialized
than the PSR might be more appropriate.
The extension of Spearman’s rank correlation to adjust for covariates using the
correlation of PSRs is an important development. In many settings, researchers are not
interested in regression coefficients, but would like a simple, single number summary of
the strength of relationship between variables, after controlling for other variables, that
is given in a constant scale regardless of the type of outcome. Our definition of
Spearman’s partial rank correlation provides such a summary measure, and it estimates
a sensible population parameter.
The examples described in this chapter have focused on univariate outcomes. Of
particular interest would be whether some of these approaches could be of value with
multivariate data, for example in the analysis of repeated measures data. We are also
interested in examining the utility of Spearman’s partial rank correlation using PSRs
where at least one of the outcomes is a time-to-event. These represent areas of future
research.
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